Atlas Trials

A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly

Clinical trial NCT04668352 · COMPLETED

Trial details

NCT number
NCT04668352
Sponsor
Restorbio Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Respiratory Tract Infections
Start date
2019-04-15
Primary completion
2019-12-02
Enrollment
1024

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.